Objective: to analyze the evidence available in the literature on the alterations in the sexuality of candidates and recipients of liver transplantation. Method: integrative review of the literature with search for primary studies in the databases MEDLINE (via PUBMED), CINAHL e LILACS, published in English, Portuguese and Spanish. Results: the 16 primary studies included were grouped into three categories: 1) female sexuality (n=5), 2) male sexuality (n=5) and 3) male and female sexuality (n=6). In category 1, the subjects investigated were contraception, pregnancy, sexual dysfunction, presence of gynecological symptoms and sexually transmitted infections. In category 2, the main focus of the studies was erectile dysfunction, sexual desire and satisfaction, and consequences of the immunosuppressive regimen with mycophenolic acid in men. In category 3, the evaluation of sexual function was the main topic. Conclusion: the scientific evidence generated provides support to encourage health professionals to incorporate the topic of sexuality in the routine of care. Knowledge gaps were identified and new studies should be conducted in order to implement interventions to prevent, minimize and/or control changes related to the patient's sexuality.
Introduction
End-stage liver disease significantly reduces quality of life. In this context, the transplantation can reverse the terminal stage and improve the patients' health conditions (1) .
According to the World Health Organization (WHO), sexuality is a central aspect of being human throughout the life cycle that encompasses sex, gender identities, sexual orientation, eroticism, pleasure, intimacy and reproduction.
It is manifested in different forms by the individuals and can be influenced by the interaction of biological, psychological, social, economic, political, cultural, historical and religious factors (2) . In general, there is evidence in the literature that both liver transplant candidates and recipients may suffer some degree of sexual dysfunction, either temporary or permanent (3) .
In liver transplant candidates, sexual dysfunction is common and related to the changes triggered by the chronic liver disease, to the drug therapy, hormonal changes, irrigation of the pelvis and emotional changes. Men may experience symptoms such as difficulty in erection, loss of libido, premature ejaculation and oligospermia. Women may be affected by ovarian dysfunction, amenorrhea, decreased or absent libido and infertility. Sexual health is complex because it involves different factors, such as age, use of medications, and social and psychological aspects coming from previous experiences or from the transplantation (4) (5) .
The feelings of well-being and improved clinical status after transplantation are related to the success of the procedure. However, problems such as the side effects of immunosuppressive drugs and the risk of postoperative complications, such as the possibility of graft failure, rejections and vascular thrombosis, may be stressors for the patient (6) . Liver transplantation can improve the patients' quality of life; however, there is evidence that not all patients experience the same benefits (7) . The chronic condition of the patient in both phases of transplantation (before and after surgery) represents a battle for quality of life, which is altered by the disease and by the treatment it requires (7) . Thus, one of the first aspects of life affected by the physical and emotional symptoms is sexual function (8) . With the prospect of performing the transplant, the patient focuses his thoughts on survival and recovery. After the transplant, new perspectives and life plans emerge, allowing the resumption of intimacy and favoring sexual activity (4) . Sexuality is a complex area of human behavior and it should not be underestimated, both for the transplant candidate and the transplant recipient. Sexual function is influenced by disease, psychological distress, and imbalance of interpersonal relationships. In most cases, chronic disease is associated with sexual dysfunction and results in decreased sexual activity due to discomfort, fatigue and changes in body image, which significantly affects the patient's relationship with the partner (7, 9) . A systematic review with meta-analysis of observational studies aimed to evaluate the effect of liver transplantation on endocrine and sexual function in adult patients. The results suggested that liver transplantation improves the hormonal perturbations associated with chronic liver disease by restoring physiological levels of growth hormone, insulinlike growth factor, testosterone, estradiol, prolactin, folliclestimulating hormone and luteinizing hormone. The 21 studies analyzed demonstrated that liver transplantation was associated with improved sexual function (8) .
Given the above and considering that the subject of sexuality of candidates and recipients of solid organs is scarcely investigated, specifically regarding liver transplantation, and that health professionals need to be prepared to address this issue with patients in health services, the interest in conducting this integrative review is justified, since its results can generate evidence to support the care provided. Thus, the objective of the present review was to analyze the evidence available in the literature on the changes in the sexuality of candidates and recipients of liver transplantation.
Method
Integrative review (IR) of the literature was the method of knowledge synthesis used. For this method, five steps were taken: elaboration of the research question (identification of the problem), literature search for primary studies, evaluation of primary studies, data analysis and presentation of the review (10) .
To guide the IR, based on the PECOT strategy (acronym for patient, exposure, comparison, outcomes and time), the following question was formulated: "What evidence is available in the literature about changes in the sexuality of liver transplant candidates and recipients?".
The first element (P = patient or problem) are the candidates and recipients of liver transplantation, the second (E = exposure) is sexuality, the third element (O = outcomes or results) are alterations related to sexuality and (T=time) is the pre-and post-operative periods.
The search for primary studies was performed through an online search in three health databases: Figure 2 shows the flowchart for the selection of primary studies.
Medical Literature Analysis and Retrieval System Online
An instrument developed by a national researcher was used to extract data from primary studies.
The instrument contains a set of items that enable the identification of researches, methodological characteristics, main results and conclusions (11) .
For the evaluation of the studies, the definition of the type of research described by the authors was maintained and, when this information was absent, the concepts described by nursing researchers in scientific methodology were used to classify the methodological approach used in the research (12) .
The hierarchy of evidence was classified according and the lowest, level VII, evidence from expert opinion) (13) .
The synthesis of the results of the review was descriptive. Thus, the 16 primary studies included in the review sample were grouped into three categories: (1) "female sexuality" (n=5), (2) "male sexuality" (n=5), and (3) "male and female sexuality" (n=6). 
Acronym

Results
Regarding the database, 13 primary studies 
To determine gynecologic symptoms and sexual function in candidates and recipients of liver transplantation.
The rates of amenorrhea were 44% for candidates and 27% for recipients. There was greater prevalence of amenorrhea in patients with hepatocellular cirrhosis compared with cholestatic disease. The transplanted women reported a more intense menstrual period and a lower frequency of urinary incontinence than the candidates.
IV
Tarallo et al.
To assess the prevalence and risk factors for high-risk HPV † infection among female liver transplant candidates.
Pap smear was normal in 58 participants (93.5%), while five (6.5%) had atypical squamous cells of undetermined significance. The HPV † test identified 10 women (16.1%), ages 46-61 years, with the high-risk virus. All women with high-risk HPV † had hepatic cirrhosis due to the hepatitis C virus, and 90% of them had no risk factors for HPV † (p=0.0013).
SzpotanskaSikorska et al. (16) To evaluate the proportion of contraceptive users and the level of satisfaction during the pre-and post-transplantation of kidney and liver.
Of the recipients of liver transplantation, 33% were unaware of the need to prevent pregnancy after surgery. Those who used drugs contraindicated for pregnancy only became aware of the situation when they became pregnant. Only 30% of kidney recipients and 29% of liver recipients used contraceptive methods. There was an increase in the use of contraceptives in sexually active women after liver transplantation. The choice of contraceptives depended on medical recommendation and on the absence of interference of the method in the body.
Szymusik, et al. (17) To assess whether female graft recipients apply proper family planning methods and use effective contraception.
There was improvement in the regularity of the menstrual cycle after liver transplantation. Liver transplant recipients became sexually more active postoperatively. After surgery, 18 women became pregnant, of which 6 (33.3%) were unplanned pregnancies. Sexually active transplanted women used fewer contraceptives than women in the control group. In addition, sexually active transplant recipients with chronic diseases used IUDs ‡ more often than women in the control group.
II
Rafie et al. (18) To evaluate counseling on the use of contraceptives and contraceptive methods among women after solid-organ transplant.
67% of transplanted women received counseling on pregnancy. Only 33% of the patients reported they had received information on the risk of pregnancy in the 1st year of transplantation, and 90% were aware of the risk of fetal deformity. The condom was the most used method. No patient received orientation from the gynecologist. 48% of the recipients were interested in receiving orientation on effective methods such as the IUD ‡ . 
IV
To determine the frequency and risk factors for ED † and satisfaction with erection among men after liver transplantation.
15% of recipients were sexually inactive after transplantation, 5% were active before surgery and became sexually inactive after, 10% remained inactive in both periods and 19% became sexually active after transplantation. The absence of sexual activity after surgery was associated with age, history of cardiovascular disease, use of diuretics, anticoagulants, non-steroidal anti-inflammatory drugs, statins and treatment for diabetes mellitus.
Huyghe et al. (20) To determine the prevalence and risk factors for ED † in men with end-stage liver disease candidates to liver transplantation.
Of the participants, 28.6% were considered sexually inactive. Among the sexually active, 74% had ED † . The risk factors for this condition were alcohol intake, tobacco use and cardiovascular disease. The risk factors for low sexual satisfaction were viral hepatitis and cardiovascular disease. Concern about erection was cited by 61.4% of sexually active men.
Wang et al. (21) To assess ED † in men with hepatic failure due to benign disease, candidates and recipients of liver transplantation.
Liver transplant recipients were more sexually active than the candidates. For the recipients, the mean time to restore libido was 60 days and the mean time to recover sexual activity was 90 days after surgery. Severe and total ED † were higher among candidates. Recipients that used cyclosporine presented less problems with ED † . IV Jones et al. (22) To describe the outcomes of pregnancies with exposure to mycophenolic acid at the time of conception.
Of 830 men enrolled in the NTPR, 152 were exposed to mycophenolic acid, generating 205 pregnancies, of which 194 were live births and 14 spontaneous abortions. Of the live births, 10.8% were premature, 4.1% were born with low weight and 3.1% presented malformations, which was similar to the general population.
Chien et al. (23) To assess differences in erectile and sexual function in the preand post-surgical period of liver transplantation with a living donor.
Erectile function improved significantly after transplantation. Hypogonadism before surgery was associated with improvement in erectile function after transplantation. There was a significant correlation between hypogonadism and erectile function before liver transplantation. 
To describe the frequency and extent of SD † in liver transplant recipients before and after surgery.
23.8% of men and 24.1% of women had sexual problems before surgery, with evolution to 51.1% and 40.3%, respectively, after transplantation. Men reported decreased libido, problems with premature ejaculation, erectile dysfunction and difficulties reaching orgasm after surgery. Women reported decreased libido, difficulty maintaining lubrication, dyspareunia, and inability to reach orgasm after transplantation.
Sorrell et al. (25) To assess the prevalence of SD † in cases of liver failure, before and after liver transplantation.
Increased age and more severe liver disease were related to lower sexual frequency and satisfaction. There was persistence of SD † after surgery. Interest (35.1%) and ability to reach orgasms (45.4%) increased after surgery, but frequency (38.9%) and satisfaction (44.4%) decreased during this period. (26) To assess the prevalence of SD † in patients with HC ‡ and patients submitted to liver transplantation.
IV Burra
Women with HC
‡ had a decrease in testosterone levels and increase in prolactin and delta-4 androstenedione compared to transplant recipients. Men with HC ‡ , had higher levels of prolactin and sex hormone binding globulin compared to transplant recipients. The percentage of severe erectile dysfunction was higher in CH ‡ patients than in transplant recipients. IV Park et al. (27) To assess SD † and sexuality of liver transplant recipients.
Males presented moderate to severe SD † and erectile dysfunction. 58.8% of women had SD † . Personal suffering related to sexuality was significant in women (40.6%) and in men (62,9%). IV Klein et al.
To assess sexual function and conjugal satisfaction in candidates and recipients of liver transplantation.
In men, sexual function improved after surgery when compared to transplant candidates, but was worse compared to healthy subjects. In women, the sexual function improved in the post-operative period when compared with female candidates. Age, body mass index, hypertension, diabetes mellitus and dyslipidemia were associated with worsening of sexual function after liver transplantation in men and women.
To analyze the prevalence and risk factors of anal HPV § infection in liver transplant recipients.
The prevalence of anal HPV infection § was 18%. Anal HPV § infection rate was higher in patients with the hepatitis B virus, with three or more sexual partners and alcoholic HC ‡ . Hepatitis B infection was a factor associated with high-risk HPV infection. 
Discussion
Primary studies grouped in the category "female sexuality" had as main topics of investigation: contraception and pregnancy (16) (17) (18) , sexual dysfunction and of gynecological symptoms (14) , and sexually transmitted infections (15) . In women, hepatic cirrhosis can lead to the development of amenorrhea, premature menopause and infertility due to reduced secretion of gonadotropins. In addition, low estradiol levels lead to reduced libido, vaginal dryness and dyspareunia (14, (16) (17) .
In the category "male sexuality", erectile dysfunction was the main focus of the studies (19) (20) (21) 23) . In two
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studies, the authors also investigated sexual desire and satisfaction (19) (20) and one study (22) investigated the consequences for newborns generated by men who impregnated their partners while using drugs with mycophenolic acid.
In the category regarding both genders, the evaluation of sexual function was the main topic of the primary studies. In three studies, measurements were made using the International Index of Erectile Function (IIEF) and Female Sexual Function Index (FSFI) (3, (26) (27) . The authors also used other scales, such as: the Beck Depression Inventory (instrument to evaluate depression), the Short Form (36) Health Survey (scale to evaluate quality of life) (26) , the Locke-Wallace
Marital Adjustment Test (instrument to evaluate marital satisfaction) (3) and the Female Distress Scale -Revised (FSDS-R), a scale that evaluates personal suffering related to sexuality (27) . In two studies (24) (25) , the authors adopted their own data collection questionnaire.
In transplanted women, the menstrual cycle returns to normal up to one year after surgery, allowing women of childbearing age to be mothers after one or two year of their transplantation, according to doctor's recommendations (14, 29) . However, transplanted women need special care due to the use of teratogenic drugs during time of pregnancy. Therefore, pregnancy must be planned in order to avoid maternal-fetal complications and transplant graft dysfunction. The results of the primary studies included in the review (n=3) showed that transplanted women were little aware of the problem and health professionals did not provide proper orientation about the need for family planning and effective contraceptive methods. Therefore, female transplant recipients exposed themselves, the fetus and the organ received to risks (16) (17) (18) .
There are gaps in knowledge about which contraceptive method is recommended for transplanted women. In some studies, the authors contraindicate the use of the IUD, due to the potential risk of infection, especially in people with immunosuppression (30) (31) . In other studies, the authors argue that the use of the intrauterine device by transplanted women is safe and the greater occurrence of pelvic infection due to immunosuppression is a myth, and there is no absolute contraindication for its use (32) (33) . Therefore, further studies are necessary to investigate which contraceptive methods are most suitable for this group of women.
However, it is clear that the method of choice should be one that does not present drug interaction with immunosuppressants and that does not pose a risk to the health of the transplant recipient. The need to use condoms is emphasized, since, despite having a failure rate of 18%, the condom is still the only barrier method capable of preventing against sexually transmitted infections (34) .
It is necessary to conduct studies on the type of delivery most appropriate for women who were submitted to transplantation. Vaginal birth can minimize complications that could occur in a caesarean section, since women who underwent transplant surgery are likely to have adhesions and fibrosis resulting from abdominal surgery. However, because the gestation of these women is considered of high-risk, caesarean sections occur more often than vaginal delivery (35) (36) (37) . It is evident that the route of delivery selected should be one that does not cause risks to the health of the fetus and the mother.
Breastfeeding by transplant mothers is a controversial subject, and scholars must conduct future research on the care of newborns. Breastfeeding is discouraged by some authors, while others question the benefit-risk of depriving the newborn of maternal nutrition, since the fetus has already been exposed to immunosuppressive drugs during gestation. In addition, the amount of drugs excreted in breast milk would not be sufficient to cause harm to the baby (37) (38) (39) .
As a suggestion, it would be of great value to create a Brazilian registry system on pregnant women and transplant recipients, so that post-transplant maternity and paternity and the effects of drugs on fertility, pregnancy and conception could be investigated. In addition, transplantation centers in Brazil must record data regarding this problem in the Transplant Pregnancy Registry International.
Regarding the health of children generated by parents using immunosuppressive drugs, according to the Food and Drug Administration (FDA), the prevalence of health problems observed was similar to outcomes found in the general population (22) .
The guidance and orientation provided by health professionals about birth control and the use of contraceptive methods cannot be only for the female audience, since men who want to be fathers also require care during the pregnancy of the partner. This is due to the use of teratogenic immunosuppressive drugs during conception, as well as the use of some classes of anti rejection drugs that provoke testicular toxicity, affecting male fertility (22, 40) . (19, 21, 23) .
Decreased libido and sexual interest were identified and may take up to eighteen months to occur (19) .
In the analysis of the occurrence of sexual dysfunction in men and women who were candidates and recipients of other solid organs such as kidney and heart, the results were similar to those identified in liver transplantation, that is, not all transplanted patients presented global recovery of sexual health. The prognosis of sexual dysfunction is related to the sexual function presented by the individual before being affected by the disease that led to the transplantation. In other words, patients who had good sexual health, even with sexual function impaired by the disease, had a greater chance of recovery after transplantation than those who already had low sexual health prior to disease (41) .
The results of studies included in the review pointed out that contraceptive counseling for men and women is deficient and often occurs at an inappropriate time, that is, shortly after transplantation, when the recipient receives a high amount of information and goes through new experiences that require an adaptation phase, even if the person has been well prepared, theoretically, for the confrontations subsequent to surgery (16) (17) (18) . When the guidelines for birth control are not assimilated or incorporated because the patient is focused on recovery after transplantation, sexuality will become more important after primary basic needs are met. .
As already pointed out, the majority (n=14) of the primary studies included in the review was classified with level of evidence IV (qualitative or descriptive study), indicating the need to conduct future research with strong designs on the issue of interest, providing evidence that can generate impact on decision making.
No study was identified in the LILACS database, which may indicate lack of publications on the topic of interest in Latin American and Caribbean journals.
Conclusion
The sexual alterations most prominent among candidates and recipients of liver transplant were sexual dysfunctions, manifested in men by impotence and in women by amenorrhea and dyspareunia. Decreased libido and sexual interest was also evident in this public.
Satisfactory sexual health is fundamental for quality of life and, therefore, must be part of the anamnesis. 
